May 7, 2024

More Men Are Becoming Alzheimer’s Caregivers. Advice from Former Wisconsin Governor Schreiber, Author of My Two Elaines: Learning, Coping, and Surviving as an Alzheimer's Caregiver

More Men Are Becoming Alzheimer’s Caregivers. Advice from Former Wisconsin Governor Schreiber, Author of My Two Elaines: Learning, Coping, and Surviving as an Alzheimer's Caregiver

About This Episode

Traditionally two-thirds of unpaid family caregivers have been women, but that is changing. Men now account for more than 40% of those caring for a spouse or aging parent with dementia. Former Wisconsin Governor Martin Schreiber talks with host Meryl Comer about his caregiving journey. Schreiber recounts his wife by his side during 16 years in public service, but his nearly two decade journey as her caregiver provides insight that he shares in his book, My Two Elaines: Learning, Coping, and Surviving as an Alzheimer's Caregiver. Schreiber discusses how to handle the challenges faced by male caregivers when it comes to managing intimate tasks of daily living and shares personal anecdotes. When asked how he endured, he replied “I remember the good times.” You won’t want to miss this episode!

Support the Show.

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW